Annual Short Term Debt:
$47.29M+$40.95M(+645.65%)Summary
- As of today, ARWR annual short term debt is $47.29 million, with the most recent change of +$40.95 million (+645.65%) on September 30, 2025.
- During the last 3 years, ARWR annual short term debt has risen by +$44.51 million (+1603.49%).
- ARWR annual short term debt is now at all-time high.
Performance
ARWR Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Short Term Debt:
$47.29M+$279.00K(+0.59%)Summary
- As of today, ARWR quarterly short term debt is $47.29 million, with the most recent change of +$279.00 thousand (+0.59%) on September 1, 2025.
- Over the past year, ARWR quarterly short term debt has increased by +$40.95 million (+645.65%).
- ARWR quarterly short term debt is now -34.12% below its all-time high of $71.78 million, reached on March 31, 2025.
Performance
ARWR Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Short Term Debt Formula
Short-Term Debt = Current Portion of Long-Term Debt + Short-Term Loans + Commercial Paper + Other Short-Term Borrowings
ARWR Short Term Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | +645.6% | +645.6% |
| 3Y3 Years | +1603.5% | +1603.5% |
| 5Y5 Years | +4219.4% | +4219.4% |
ARWR Short Term Debt Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +1603.5% | -34.1% | +1675.1% |
| 5Y | 5-Year | at high | +4219.4% | -34.1% | +4219.4% |
| All-Time | All-Time | at high | >+9999.0% | -34.1% | >+9999.0% |
ARWR Short Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2025 | $47.29M(+645.6%) | - |
| Sep 2025 | - | $47.29M(+0.6%) |
| Jun 2025 | - | $47.01M(-34.5%) |
| Mar 2025 | - | $71.78M(+777.0%) |
| Dec 2024 | - | $8.19M(+29.1%) |
| Sep 2024 | $6.34M(-40.0%) | $6.34M(+4.8%) |
| Jun 2024 | - | $6.05M(+14.5%) |
| Mar 2024 | - | $5.29M(+54.5%) |
| Dec 2023 | - | $3.42M(-67.6%) |
| Sep 2023 | $10.56M(+280.5%) | $10.56M(+274.2%) |
| Jun 2023 | - | $2.82M(+4.1%) |
| Mar 2023 | - | $2.71M(+1.8%) |
| Dec 2022 | - | $2.66M(-4.0%) |
| Sep 2022 | $2.78M(+23.4%) | $2.78M(-3.7%) |
| Jun 2022 | - | $2.88M(-0.9%) |
| Mar 2022 | - | $2.91M(+3.0%) |
| Dec 2021 | - | $2.83M(+25.6%) |
| Sep 2021 | $2.25M(+105.5%) | $2.25M(+74.4%) |
| Jun 2021 | - | $1.29M(+1.4%) |
| Mar 2021 | - | $1.27M(+7.5%) |
| Dec 2020 | - | $1.18M(+8.1%) |
| Sep 2020 | $1.09M(>+9900.0%) | $1.09M(+8.2%) |
| Jun 2020 | - | $1.01M(+47.0%) |
| Mar 2020 | - | $688.50K(+49.3%) |
| Dec 2019 | - | $461.20K(>+9900.0%) |
| Sep 2019 | $0.00(-100.0%) | $0.00(0.0%) |
| Jun 2019 | - | $0.00(0.0%) |
| Mar 2019 | - | $0.00(0.0%) |
| Dec 2018 | - | $0.00(-100.0%) |
| Sep 2018 | $223.80K(+7.3%) | $223.80K(+1.8%) |
| Jun 2018 | - | $219.90K(+1.8%) |
| Mar 2018 | - | $216.00K(+1.8%) |
| Dec 2017 | - | $212.20K(+1.8%) |
| Sep 2017 | $208.50K(+7.3%) | $208.50K(+1.8%) |
| Jun 2017 | - | $204.80K(+1.8%) |
| Mar 2017 | - | $201.20K(+1.8%) |
| Dec 2016 | - | $197.70K(+1.7%) |
| Sep 2016 | $194.30K(-10.7%) | $194.30K(-46.2%) |
| Jun 2016 | - | $361.10K(+64.7%) |
| Mar 2016 | - | $219.30K(+0.4%) |
| Dec 2015 | - | $218.40K(+0.4%) |
| Sep 2015 | $217.50K(-17.6%) | $217.50K(+0.4%) |
| Jun 2015 | - | $216.70K(+0.4%) |
| Mar 2015 | - | $215.80K(+0.8%) |
| Dec 2014 | - | $214.00K(-18.9%) |
| Sep 2014 | $264.00K(-77.9%) | $264.00K(+0.3%) |
| Jun 2014 | - | $263.10K(-79.2%) |
| Mar 2014 | - | $1.26M(-0.7%) |
| Dec 2013 | - | $1.27M(+6.6%) |
| Sep 2013 | $1.19M(+455.4%) | $1.19M(+4.2%) |
| Jun 2013 | - | $1.15M(+4.3%) |
| Mar 2013 | - | $1.10M(-4.6%) |
| Dec 2012 | - | $1.15M(+436.2%) |
| Sep 2012 | $214.80K | $214.80K(+0.8%) |
| Jun 2012 | - | $213.20K(+0.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2012 | - | $211.60K(+1.0%) |
| Dec 2011 | - | $209.60K(>+9900.0%) |
| Sep 2011 | $0.00(-100.0%) | $0.00(0.0%) |
| Jun 2011 | - | $0.00(0.0%) |
| Mar 2011 | - | $0.00(-100.0%) |
| Dec 2010 | - | $500.00K(0.0%) |
| Sep 2010 | $500.00K(-31.2%) | $500.00K(-13.0%) |
| Jun 2010 | - | $574.80K(-27.8%) |
| Mar 2010 | - | $796.40K(-21.4%) |
| Dec 2009 | - | $1.01M(+39.5%) |
| Sep 2009 | $726.50K(-10.4%) | $726.50K(-15.6%) |
| Jun 2009 | - | $860.40K(+2.0%) |
| Mar 2009 | - | $843.40K(+2.0%) |
| Dec 2008 | - | $826.80K(+2.0%) |
| Sep 2008 | $810.50K(>+9900.0%) | $810.50K(>+9900.0%) |
| Jun 2008 | - | $0.00(0.0%) |
| Mar 2008 | - | $0.00(0.0%) |
| Dec 2007 | - | $0.00(0.0%) |
| Sep 2007 | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2007 | - | $0.00(0.0%) |
| Mar 2007 | - | $0.00(0.0%) |
| Dec 2006 | - | $0.00(0.0%) |
| Sep 2006 | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2006 | - | $0.00(0.0%) |
| Mar 2006 | - | $0.00(0.0%) |
| Dec 2005 | - | $0.00(0.0%) |
| Sep 2005 | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2005 | - | $0.00(0.0%) |
| Mar 2005 | - | $0.00(0.0%) |
| Dec 2004 | - | $0.00(0.0%) |
| Sep 2004 | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2004 | - | $0.00(0.0%) |
| Mar 2004 | - | $0.00(0.0%) |
| Dec 2003 | - | $0.00(0.0%) |
| Sep 2003 | $0.00(-100.0%) | $0.00(-100.0%) |
| Jun 2003 | - | $602.00K(-0.2%) |
| Mar 2003 | - | $603.00K(-0.5%) |
| Dec 2002 | - | $606.00K(0.0%) |
| Sep 2002 | $606.00K(+15.2%) | $606.00K(0.0%) |
| Jun 2002 | - | $606.00K(+19.8%) |
| Mar 2002 | - | $506.00K(-3.8%) |
| Dec 2001 | - | $526.00K(0.0%) |
| Sep 2001 | $526.00K(+0.4%) | $526.00K(0.0%) |
| Jun 2001 | - | $526.00K(0.0%) |
| Mar 2001 | - | $526.00K(+0.2%) |
| Dec 2000 | - | $525.00K(+0.2%) |
| Sep 2000 | $524.00K(+0.4%) | $524.00K(+0.2%) |
| Jun 2000 | - | $523.00K(-0.4%) |
| Mar 2000 | - | $525.00K(0.0%) |
| Dec 1999 | - | $525.00K(+0.6%) |
| Sep 1999 | $522.00K(-49.1%) | $522.00K(0.0%) |
| Jun 1999 | - | $522.00K(-50.0%) |
| Mar 1999 | - | $1.04M |
| Sep 1998 | $1.02M(+0.1%) | - |
| Sep 1997 | $1.02M | - |
FAQ
- What is Arrowhead Pharmaceuticals, Inc. annual short term debt?
- What is the all-time high annual short term debt for Arrowhead Pharmaceuticals, Inc.?
- What is Arrowhead Pharmaceuticals, Inc. annual short term debt year-on-year change?
- What is Arrowhead Pharmaceuticals, Inc. quarterly short term debt?
- What is the all-time high quarterly short term debt for Arrowhead Pharmaceuticals, Inc.?
- What is Arrowhead Pharmaceuticals, Inc. quarterly short term debt year-on-year change?
What is Arrowhead Pharmaceuticals, Inc. annual short term debt?
The current annual short term debt of ARWR is $47.29M
What is the all-time high annual short term debt for Arrowhead Pharmaceuticals, Inc.?
Arrowhead Pharmaceuticals, Inc. all-time high annual short term debt is $47.29M
What is Arrowhead Pharmaceuticals, Inc. annual short term debt year-on-year change?
Over the past year, ARWR annual short term debt has changed by +$40.95M (+645.65%)
What is Arrowhead Pharmaceuticals, Inc. quarterly short term debt?
The current quarterly short term debt of ARWR is $47.29M
What is the all-time high quarterly short term debt for Arrowhead Pharmaceuticals, Inc.?
Arrowhead Pharmaceuticals, Inc. all-time high quarterly short term debt is $71.78M
What is Arrowhead Pharmaceuticals, Inc. quarterly short term debt year-on-year change?
Over the past year, ARWR quarterly short term debt has changed by +$40.95M (+645.65%)